Search Results
Anne-Sophie C A M Koning
Anne-Sophie C A M Koning
Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Anne-Sophie C A M Koning in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Anne-Sophie C A M Koning in
Google Scholar
PubMed
Philippe C Habets
Philippe C Habets
Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Philippe C Habets in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Philippe C Habets in
Google Scholar
PubMed
Marit Bogaards
Marit Bogaards
Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Marit Bogaards in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Marit Bogaards in
Google Scholar
PubMed
Jan Kroon
Jan Kroon
Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Jan Kroon in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Jan Kroon in
Google Scholar
PubMed
Hanneke M van Santen
Hanneke M van Santen
Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands
Department of Pediatric Neuro-Oncology, Prinses Máxima Centrum, Utrecht, The Netherlands
Search for other papers by Hanneke M van Santen in
Google Scholar
PubMed
Department of Pediatric Neuro-Oncology, Prinses Máxima Centrum, Utrecht, The Netherlands
Search for other papers by Hanneke M van Santen in
Google Scholar
PubMed
Judith M de Bont
Judith M de Bont
Department of Pediatric Neuro-Oncology, Prinses Máxima Centrum, Utrecht, The Netherlands
Search for other papers by Judith M de Bont in
Google Scholar
PubMed
Search for other papers by Judith M de Bont in
Google Scholar
PubMed
Onno C Meijer
Onno C Meijer
Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Onno C Meijer in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Onno C Meijer in
Google Scholar
PubMed
Introduction Synthetic glucocorticoids are used extensively for their anti-inflammatory effects in many medical conditions, including immune diseases, different types of cancer, and in the treatment of edema in brain tumor patients ( 1 , 2
Charlotte Höybye
Charlotte Höybye
Department of Endocrinology and Department of Molecular Medicine and Surgery, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden
Search for other papers by Charlotte Höybye in
Google Scholar
PubMed
Search for other papers by Charlotte Höybye in
Google Scholar
PubMed
Beverly M K Biller
Beverly M K Biller
Neuroendocrine Unit, Massachusetts General Hospital, Massachusetts General Hospital, Boston, Massachusetts, USA
Search for other papers by Beverly M K Biller in
Google Scholar
PubMed
Search for other papers by Beverly M K Biller in
Google Scholar
PubMed
Jean-Marc Ferran
Jean-Marc Ferran
Qualiance ApS, Copenhagen, Denmark
Search for other papers by Jean-Marc Ferran in
Google Scholar
PubMed
Search for other papers by Jean-Marc Ferran in
Google Scholar
PubMed
Murray B Gordon
Murray B Gordon
Allegheny Neuroendocrinology Center, Division of Endocrinology, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA
Search for other papers by Murray B Gordon in
Google Scholar
PubMed
Search for other papers by Murray B Gordon in
Google Scholar
PubMed
Nicky Kelepouris
Nicky Kelepouris
US Medical Affairs-Rare Endocrine Disorders, Novo Nordisk, Inc, Plainsboro, New Jersey, USA
Search for other papers by Nicky Kelepouris in
Google Scholar
PubMed
Search for other papers by Nicky Kelepouris in
Google Scholar
PubMed
Navid Nedjatian
Navid Nedjatian
Global Medical Affairs – Rare Endocrine Disorders, Novo Nordisk Health Care AG, Zurich, Switzerland
Search for other papers by Navid Nedjatian in
Google Scholar
PubMed
Search for other papers by Navid Nedjatian in
Google Scholar
PubMed
Anne H Olsen
Anne H Olsen
Epidemiology, Novo Nordisk A/S, Soborg, Denmark
Search for other papers by Anne H Olsen in
Google Scholar
PubMed
Search for other papers by Anne H Olsen in
Google Scholar
PubMed
Matthias M Weber
Matthias M Weber
Unit of Endocrinology, 1, Medical Department, University Hospital, Universitätsmedizin Mainz, der Johannes Gutenberg-Universität, Mainz, Germany
Search for other papers by Matthias M Weber in
Google Scholar
PubMed
Search for other papers by Matthias M Weber in
Google Scholar
PubMed
metabolism, long-term GH treatment can lead to improved insulin levels and glycaemia due to concomitant body composition changes ( 10 , 11 , 12 ). Additionally, replacement with other hormones, especially pharmacological doses of glucocorticoids, might have
Agata Hanna Bryk-Wiązania
Agata Hanna Bryk-Wiązania
Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland
Search for other papers by Agata Hanna Bryk-Wiązania in
Google Scholar
PubMed
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland
Search for other papers by Agata Hanna Bryk-Wiązania in
Google Scholar
PubMed
Mari Minasyan
Mari Minasyan
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland
Search for other papers by Mari Minasyan in
Google Scholar
PubMed
Search for other papers by Mari Minasyan in
Google Scholar
PubMed
Alicja Hubalewska-Dydejczyk
Alicja Hubalewska-Dydejczyk
Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland
Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland
Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed
Aleksandra Gilis-Januszewska
Aleksandra Gilis-Januszewska
Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland
Search for other papers by Aleksandra Gilis-Januszewska in
Google Scholar
PubMed
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland
Search for other papers by Aleksandra Gilis-Januszewska in
Google Scholar
PubMed
AM Minnetti M Sbardella E Graziadio C & Grossman AB . Mechanisms in Endocrinology: The spectrum of haemostatic abnormalities in glucocorticoid excess and defect . European Journal of Endocrinology 2015 173 R101 – R113 . ( https
